The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mchutchison John G since 2018.
This trader's CIK number is 1738125.
At the time of last reporting, Mchutchison John G was the Officer of Assembly Biosciences, Inc.. (stock ticker symbol ASMB).
Also see all insider trading activities at Assembly Biosciences, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | GILD | 0 | $0 | 0 | $0 | 1,465 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ASMB | 0 | $0 | 757 | $7,454 | 0 | $0 |
2024 | ASMB | 0 | $0 | 3,323 | $47,379 | 0 | $0 |
2023 | ASMB | 0 | $0 | 40,855 | $39,258 | 0 | $0 |
2022 | ASMB | 0 | $0 | 4,614 | $9,998 | 0 | $0 |
2021 | ASMB | 0 | $0 | 12,156 | $43,785 | 0 | $0 |
2020 | ASMB | 0 | $0 | 12,151 | $268,877 | 0 | $0 |
1. Gilead Sciences, Inc. (GILD)
2. Assembly Biosciences, Inc. (ASMB)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-11-10 | GILD | Option Ex | 1,465 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-31 | ASMB | Sale | 757 | 9.85 | 7,454 |
2024-05-23 | ASMB | Sale | 2,117 | 14.93 | 31,615 |
2024-04-01 | ASMB | Sale | 1,206 | 13.07 | 15,764 |
2023-05-23 | ASMB | Sale | 25,972 | 1.04 | 27,010 |
2023-03-30 | ASMB | Sale | 14,883 | .82 | 12,248 |
2022-03-30 | ASMB | Sale | 4,614 | 2.17 | 9,998 |
2021-08-09 | ASMB | Sale | 12,156 | 3.60 | 43,785 |
2020-08-07 | ASMB | Sale | 12,151 | 22.13 | 268,877 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mchutchison John G (Officer of Assembly Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.